Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Martin Glas, Gerrit H. Gielen et al.|Journal of Translational Medicine|2019Cited by 78
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastasesSied Kebir, Martin Glas, Laurèl Rauschenbach et al.|Neuro-Oncology|2016Cited by 73
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Shanshan Wang et al.|Clinical Cancer Research|2016Cited by 72
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progressionI‐Na Lu, Igor Cima, Sied Kebir et al.|Nature Communications|2021Cited by 55
Cranioencephalic functional lymphoid units in glioblastomaCelia Dobersalske, Björn Scheffler, Laurèl Rauschenbach et al.|Nature Medicine|2024Cited by 41